
Pfizer has announced that the US FDA has approved Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) extended-release capsules for the …

Endo International has announced that, following discussions with the US Food and Drug Administration (FDA), it has decided to withdraw …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland

